
Pubmed-entry ::= {
  pmid 31079494,
  medent {
    em std {
      year 2019,
      month 5,
      day 14,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Emodin weakens liver inflammatory injury triggered by
 lipopolysaccharide through elevating microRNA-145 in vitro and in vivo."
      },
      authors {
        names std {
          {
            name ml "Xie R",
            affil str "a Department of Gastroenterology , Jining No.1 People's
 Hospital , Jining , China."
          },
          {
            name ml "Liu M",
            affil str "a Department of Gastroenterology , Jining No.1 People's
 Hospital , Jining , China."
          },
          {
            name ml "Li S",
            affil str "b Department of Rheumatology and Immunology , Jining
 No.1 People's Hospital , Jining , China."
          }
        }
      },
      from journal {
        title {
          iso-jta "Artif Cells Nanomed Biotechnol",
          ml-jta "Artif Cells Nanomed Biotechnol",
          issn "2169-141X",
          name "Artificial cells, nanomedicine, and biotechnology"
        },
        imp {
          date std {
            year 2019,
            month 12
          },
          volume "47",
          issue "1",
          pages "1877-1887",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus other,
              date std {
                year 2019,
                month 5,
                day 14,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2019,
                month 5,
                day 14,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2019,
                month 11,
                day 5,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 31079494,
        doi "10.1080/21691401.2019.1614015",
        other {
          db "ELocationID doi",
          tag str "10.1080/21691401.2019.1614015"
        }
      }
    },
    abstract "Hepatitis is a severe liver disease with worldwide distribution.
 This study explored the anti-inflammatory influence of Emodin on
 LPS-triggered liver injury in vitro and in vivo. In vitro, we discovered that
 LPS treatment triggered L-02 cell and primary hepatocyte inflammatory injury.
 Emodin weakened the LPS-triggered cell inflammatory injury and NF-kappaB
 pathway activation. Emodin alleviated LPS-stimulated decrease of miR-145
 expression. Moreover, miR-145 participated in the regulation of
 pro-inflammatory factors expression and negatively regulated IRAK1. Besides,
 IRAK1 exert regulatory roles in the activation of NF-kappaB pathway. In vivo,
 we found that Emodin pre-treatment weakened the LPS-triggered increases of
 pro-inflammatory factors expression, up-regulations of AST and ALT level,
 liver cell apoptosis, reduction of miR-145 and enhancement of IRAK1. Our
 research verified that Emodin weakened LPS-triggered liver cell inflammatory
 injury in vitro and in vivo might be achieved by elevating miR-145,
 decreasing IRAK1 and then suppressing NF-kappaB pathway.",
    mesh {
      {
        term "Animals"
      },
      {
        term "Apoptosis",
        qual {
          {
            subh "drug effects"
          },
          {
            subh "genetics"
          }
        }
      },
      {
        term "Chemical and Drug Induced Liver Injury",
        qual {
          {
            mp TRUE,
            subh "drug therapy"
          },
          {
            mp TRUE,
            subh "genetics"
          },
          {
            subh "metabolism"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Emodin",
        qual {
          {
            mp TRUE,
            subh "pharmacology"
          },
          {
            subh "therapeutic use"
          }
        }
      },
      {
        term "Female"
      },
      {
        term "Inflammation",
        qual {
          {
            subh "chemically induced"
          },
          {
            subh "genetics"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Lipopolysaccharides",
        qual {
          {
            mp TRUE,
            subh "adverse effects"
          }
        }
      },
      {
        term "Liver",
        qual {
          {
            subh "drug effects"
          },
          {
            subh "metabolism"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Male"
      },
      {
        term "MicroRNAs",
        qual {
          {
            mp TRUE,
            subh "genetics"
          }
        }
      },
      {
        term "NF-kappa B",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Rats"
      },
      {
        term "Rats, Wistar"
      }
    },
    substance {
      {
        type nameonly,
        name "Lipopolysaccharides"
      },
      {
        type nameonly,
        name "MIRN145 microRNA, rat"
      },
      {
        type nameonly,
        name "MicroRNAs"
      },
      {
        type nameonly,
        name "NF-kappa B"
      },
      {
        type cas,
        cit "KA46RNI6HN",
        name "Emodin"
      }
    },
    pmid 31079494,
    pub-type {
      "Journal Article"
    },
    status medline
  }
}


